Dr. Reddy's Launches Generic Semaglutide In Canada, Expands GLP-1 Push - Dr Reddy's Laboratories (NYSE:RD
7 Articles
7 Articles
Times of India
The Economic TimesDr Reddy’s launches generic Semaglutide injection, popular weight-loss drug, in Canada
Dr Reddy's Laboratories has launched its generic Semaglutide injection in Canada. This marks a significant step for the company in providing treatment for type 2 diabetes. Canada is the first G7 nation to approve this medication. The launch follows a recent introduction in India. Dr Reddy's aims to expand access to these therapies globally.
Indian pharmaceutical Dr. Reddy’s Laboratories announced this Saturday the launch on the Canadian market of its semaglutide injection, making Canada the first G7 country to market a generic version of the basic compound of the popular medicine Ozempic. “Dr. Reddy’s is among the first companies to introduce a generic injection of semaglutide into the Canadian market, following the notification of compliance received from the Canadian Ministry of …
stocktitan.net
Dr. Reddy's Laboratories Launches its Generic Semaglutide Injection in Canada
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
